Currently 16 wall-street analysts regularly analyze the financials of Bioxcel Therapeutics on a frequent basis to provide recommendations along with target share price. 16 analysts offering 12-month price forecasts for Bioxcel Therapeutics (BTAI) have a share price target of $19.5. This median of share price forecast represents a 586.62% upside from the latest price of $2.84 as on 28.09.23.
Bioxcel Therapeutics (BTAI) Price vs Consensus Price Target
As per the chart shown above, analysts believe that the Bioxcel Therapeutics (BTAI) share price will touch around $19.5 in next 12-months.
*Investment in securities market are subject to market risk, read all the related documents carefully before investing. Logos above are the property of their respective trademark owners and by displaying it INDmoney has no right, title or interest over it.
The connector service for US Stocks account is provided by Finzoomers Services Private Limited.
Please be informed that US Stocks are not Indian Exchange traded funds and Finzoomers Services Private Limited merely acts in the capacity of a facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to exchange investor redressal forum or arbitration mechanism in India. The securities quoted are for examples and not to be considered as an advice or recommendation.